Deyev SM - Search Results

1

Targeting GD2-Positive Tumor Cells by Pegylated scFv Fragment-Drug Conjugates Carrying Maytansinoids DM1 and DM4.

Kalinovsky DV, Kholodenko IV, Svirshchevskaya EV, Kibardin AV, Ryazantsev DY, Rozov FN, Larin SS, Deyev SM, Kholodenko RV. Kalinovsky DV, et al. Among authors: deyev sm. Curr Issues Mol Biol. 2023 Oct 5;45(10):8112-8125. doi: 10.3390/cimb45100512. Curr Issues Mol Biol. 2023. PMID: 37886955 Free PMC article.

2

Neuroblastoma Origin and Therapeutic Targets for Immunotherapy.

Kholodenko IV, Kalinovsky DV, Doronin II, Deyev SM, Kholodenko RV. Kholodenko IV, et al. Among authors: deyev sm. J Immunol Res. 2018 Jul 11;2018:7394268. doi: 10.1155/2018/7394268. eCollection 2018. J Immunol Res. 2018. PMID: 30116755 Free PMC article. Review.

3

RNA Sequencing-Based Identification of Ganglioside GD2-Positive Cancer Phenotype.

Sorokin M, Kholodenko I, Kalinovsky D, Shamanskaya T, Doronin I, Konovalov D, Mironov A, Kuzmin D, Nikitin D, Deyev S, Buzdin A, Kholodenko R. Sorokin M, et al. Biomedicines. 2020 May 30;8(6):142. doi: 10.3390/biomedicines8060142. Biomedicines. 2020. PMID: 32486168 Free PMC article.

4

Barnase encapsulation into submicron porous CaCO₃ particles: studies of loading and enzyme activity.

Yashchenok AM, Gusliakova OI, Konovalova EV, Novoselova MV, Shipunova VO, Abakumova TO, Efimova OI, Kholodenko R, Schulga AA, Zatsepin TS, Gorin DA, Deyev SM. Yashchenok AM, et al. Among authors: deyev sm. J Mater Chem B. 2021 Nov 3;9(42):8823-8831. doi: 10.1039/d1tb01315g. J Mater Chem B. 2021. PMID: 34633027

5

Therapeutic efficacy of antibody-drug conjugates targeting GD2-positive tumors.

Kalinovsky DV, Kibardin AV, Kholodenko IV, Svirshchevskaya EV, Doronin II, Konovalova MV, Grechikhina MV, Rozov FN, Larin SS, Deyev SM, Kholodenko RV. Kalinovsky DV, et al. Among authors: deyev sm. J Immunother Cancer. 2022 Jun;10(6):e004646. doi: 10.1136/jitc-2022-004646. J Immunother Cancer. 2022. PMID: 35764367 Free PMC article.

6

Minibody-Based and scFv-Based Antibody Fragment-Drug Conjugates Selectively Eliminate GD2-Positive Tumor Cells.

Kalinovsky DV, Kholodenko IV, Kibardin AV, Doronin II, Svirshchevskaya EV, Ryazantsev DY, Konovalova MV, Rozov FN, Larin SS, Deyev SM, Kholodenko RV. Kalinovsky DV, et al. Among authors: deyev sm. Int J Mol Sci. 2023 Jan 8;24(2):1239. doi: 10.3390/ijms24021239. Int J Mol Sci. 2023. PMID: 36674755 Free PMC article.

7

Targeted Delivery of HSP70 to Tumor Cells via Supramolecular Complex Based on HER2-Specific DARPin9_29 and the Barnase:Barstar Pair.

Alekseeva LG, Ovsyanikova OV, Schulga AA, Grechikhina MV, Shustova OA, Kovalenko EI, Svirshchevskaya EV, Deyev SM, Sapozhnikov AM. Alekseeva LG, et al. Among authors: deyev sm. Cells. 2024 Feb 9;13(4):317. doi: 10.3390/cells13040317. Cells. 2024. PMID: 38391930 Free PMC article.

8

Multivalency: the hallmark of antibodies used for optimization of tumor targeting by design.

Deyev SM, Lebedenko EN. Deyev SM, et al. Bioessays. 2008 Sep;30(9):904-18. doi: 10.1002/bies.20805. Bioessays. 2008. PMID: 18693269

9

Fluorescent immunolabeling of cancer cells by quantum dots and antibody scFv fragment.

Zdobnova TA, Dorofeev SG, Tananaev PN, Vasiliev RB, Balandin TG, Edelweiss EF, Stremovskiy OA, Balalaeva IV, Turchin IV, Lebedenko EN, Zlomanov VP, Deyev SM. Zdobnova TA, et al. Among authors: deyev sm. J Biomed Opt. 2009 Mar-Apr;14(2):021004. doi: 10.1117/1.3122775. J Biomed Opt. 2009. PMID: 19405717 Free article.

10

Chemical Polysialylation of Recombinant Human Proteins.

Smirnov IV, Vorobiev II, Belogurov AA, Genkin DD, Deyev SM, Gabibov AG. Smirnov IV, et al. Among authors: deyev sm. Methods Mol Biol. 2015;1321:389-404. doi: 10.1007/978-1-4939-2760-9_26. Methods Mol Biol. 2015. PMID: 26082236

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

217 results

Search Page